Skip to content
Home/Companies/MedTech/O11 biomedical

O11 biomedical

MedTech·Germany·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns O11 biomedical?

O11 biomedical is currently owned by High-Tech Gruenderfonds (HTGF) through HTGF IV (2022 vintage), since 2023.

Hand-verified · updated 2026-08-11

High-Tech Gruenderfonds (HTGF)
Investor
High-Tech Gruenderfonds (HTGF)
HTGF IV · 2022 · VC

Key facts

HQGermany
SectorMedTech
StatusActive

More from HTGF IV

Other portfolio companies in the same fund.

Clee Medical
Clee Medical
Active
MedTechSwitzerland· 2026
kausable
Active
AI/MLGermany· 2026
Mycoverse
Active
AgTechDenmark· 2026
Noxon
Active
MedTechGermany· 2026
nuuEnergy
nuuEnergy
Active
ClimateTechGermany· 2026
Pixel-Flo
Active
Deep TechUnited Kingdom· 2026

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Optos
Exited 2015
Amadeus Capital PartnersUK
to
Axomove
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Custom Surgical
Custom Surgical
Active
ZEISS VenturesGermany· 2026
Track O11 biomedical

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on O11 biomedical.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue